Ventricular Assist Device Market: USD 2.81 Bn by 2031 with Bridge-to-Transplant Therapy Segment Holding Over 48.7% Share in 2025, Says Mordor Intelligence
HYDERABAD, India, May 1, 2026 /PRNewswire/ — According to Mordor Intelligence, the ventricular assist devices market size is valued at USD 1.88 billion in 2026, rising from USD 1.73 billion in 2025, and is projected to reach USD 2.81 billion by 2031, expanding at a CAGR of 8.44% during 2026 – 2031, supported by the increasing prevalence of heart failure and the growing adoption of advanced mechanical circulatory support systems. The market expansion is driven by rising demand for life-sustaining cardiac support technologies, particularly among patients awaiting heart transplants or those ineligible for transplantation procedures.
The growth of the ventricular assist device (VAD) market is closely linked to the global rise in cardiovascular diseases. With heart failure cases increasing due to aging populations, sedentary lifestyles, and associated risk factors such as hypertension and diabetes, the demand for long-term cardiac support solutions continues to rise. Ventricular assist devices are increasingly being used as bridge-to-transplant and destination therapy, offering improved survival rates and enhanced quality of life for patients with advanced heart conditions.
Technological advancements are playing a crucial role in shaping the market landscape. Innovations such as continuous-flow devices, miniaturized components, and improved battery systems are enhancing device efficiency, durability, and patient comfort. These advancements are reducing complications and enabling better post-implant outcomes. Additionally, the integration of remote monitoring and digital health technologies is improving patient management and enabling real-time clinical decision-making.
Ventricular Assist Device Market Share by Region
North America represents a significant share of the ventricular assist device market, driven by well-established healthcare infrastructure, high adoption of advanced cardiac technologies, and favorable reimbursement scenarios. The region continues to lead in clinical research and device innovation.
Europe holds a notable position in the market, supported by increasing awareness of advanced heart failure treatments, growing healthcare investments, and the presence of leading medical device manufacturers.
Asia-Pacific is emerging as a high-growth region due to rising healthcare expenditure, improving access to cardiac care, and increasing prevalence of cardiovascular diseases in countries such as China, India, and Japan.
“Analysis of the ventricular assist devices market reflects steady clinical adoption and evolving care pathways, with findings grounded in verifiable data and consistent tracking” says Soumya Goud, Senior Research Manager, Mordor Intelligence. “The study’s disciplined validation approach and balanced interpretation provide decision-makers with a dependable view compared to less transparent alternatives.”
Ventricular Assist Device Market Trends & Forecast
Advancements in Continuous-Flow Devices
Modern continuous-flow VADs are gaining traction due to their improved durability, smaller size, and reduced risk of complications compared to earlier pulsatile devices.
Integration of Digital Health and Remote Monitoring
The incorporation of remote monitoring technologies is enhancing patient care by enabling continuous tracking of device performance and patient health metrics.
Ventricular Assist Device Market Segmentation Overview
- By Product Type
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Biventricular Assist Device (BIVAD)
- Total Artificial Heart (TAH)
- By Design
- Implantable VAD
- Transcutaneous / External VAD
- Percutaneous Micro-axial VAD
- By Application / Therapy
- Bridge-to-Transplant (BTT)
- Destination Therapy (DT)
- Bridge-to-Recovery (BTR)
- Bridge-to-Decision
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/ventricular-assist-devices-market?utm_source=prnewswire
Ventricular Assist Device Market Competitive Outlook
The ventricular assist device market features a competitive landscape characterized by established medical device manufacturers focusing on innovation, regulatory approvals, and strategic collaborations. Companies are investing in research and development to improve device performance, reduce complications, and expand clinical applications. The growing emphasis on patient-centric solutions and minimally invasive implantation techniques is further shaping competitive strategies.
Major Companies in the Ventricular Assist Device Market include:
- Abbott Laboratories
- Medtronic PLC
- Berlin Heart GmbH
- Terumo Corporation
- SynCardia Systems, LLC
Check out related reports published by Mordor Intelligence:
Bone Grafts and Substitutes Market Size
The bone grafts and substitutes market is estimated at USD 4.41 billion in 2026 and is projected to reach USD 5.75 billion by 2031, registering a CAGR of 5.45% during the forecast period. Growth is driven by increasing orthopedic procedures, rising incidence of bone-related disorders, and growing adoption of advanced biomaterials in surgical treatments.
Medtronic Plc, Zimmer Biomet, Stryker Corporation, Johnson and Johnson, and Smith are the major companies operating in this market.
Read more about the companies in the Bone Grafts and Substitutes Market: https://www.mordorintelligence.com/industry-reports/bone-grafts-and-substitutes-market/companies?utm_source=prnewswire
Refractive Surgery Devices Market Share
The refractive surgery devices market stood at USD 254.7 million in 2025 and is expected to reach USD 397.0 million by 2030, growing at a CAGR of 9.30% during the forecast period. Market expansion is supported by increasing demand for vision correction procedures, rising prevalence of refractive errors, and growing adoption of advanced laser technologies.
Cardiopulmonary Bypass Equipment Market Trends
The cardiopulmonary bypass equipment market is estimated at USD 381.52 million in 2026 and is projected to reach USD 465.82 million by 2031, registering a CAGR of 4.07% during the forecast period. Growth is driven by increasing cardiac surgeries, rising prevalence of cardiovascular diseases, and growing demand for advanced surgical support equipment in healthcare facilities.
Know more about Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
View original content:SOURCE Mordor Intelligence Private Limited
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. USA Newshour takes no editorial responsibility for the same.
